Home › Funds › KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC › GMED
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC position in GMED
GLOBUS MED INC · Health Care
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reported holding 3,196,729 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$239.4M, representing 0.90% of its reported portfolio and ranking #35 among its reported holdings. KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC has disclosed GMED holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC's GMED position evolved
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC first disclosed a stake in GMED in Q3 2023 at 7 shares (US$0K). The position peaked in Q2 2026 at 4,279,730 shares, worth US$338.1M. Across 4 filings, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,196,729 shares valued at US$239.4M — a reduction of -1,083,001 shares quarter over quarter.. Notable position changes include a 25% trim in Q3 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 7 | $348 | New |
| Q4 2023 | 7 | $373 | Hold |
| Q2 2026 | 4.28M | $338.14M | New |
| Q3 2026 | 3.20M | $239.44M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMED and 13F data
GMED (GLOBUS MED INC) is a Health Care company. 34 other funds we track also report a position in GMED — the largest reported positions include Boston Trust Walden Corp (US$123.1M), GW&K Investment Management, LLC (US$110.3M), GENEVA CAPITAL MANAGEMENT LLC (US$93.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMED
- Boston Trust Walden Corp 1.64M sh · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M sh · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M sh · $93.58M · Q3 2026
- Madison Avenue Partners, LP 935.22K sh · $73.89M · Q2 2026
More on KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
FAQ
How long has KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC held GMED?
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC has disclosed GMED holdings in 4 of the last 13 reported quarters, going back to Q3 2023.
What is KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC's current position in GMED?
As of Q3 2026, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 3.20M shares of GMED (GLOBUS MED INC), valued at $239.44M, representing 0.90% of its reported portfolio and ranking #35.
Has KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC been buying or selling GMED?
In the latest 13F filing (Q3 2026), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reduced its position in GMED. The position peaked in Q2 2026 at 4.28M shares.
Which other funds hold GMED?
Other major institutional holders of GMED include Boston Trust Walden Corp, GW&K Investment Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.